Tulavi Therapeutics

Tulavi Therapeutics is dedicated to developing new therapies to treat neurally mediated disease.

FOUNDERS

Corinne Bright
President and CEO


Corinne is the co-Founder of Tulavi Therapeutics and the Founder and CEO of Reflex Medical, Prior to that, she was a Principal at ONSET Ventures, focusing on early-stage medical device investments.  Previously, she was Vice President, Research and Development at Talima Therapeutics, a privately-held start-up company developing a biodegradable drug-device combination product for the treatment of onychomycosis where she led product development from concept through Phase II clinical trials.  Prior to Talima, she was a Biodesign Innovation Fellow at Stanford University focusing on unmet clinical needs in neurology, interventional radiology and neurosurgery.  Corinne holds a B.S. in Engineering from Swarthmore College and a Ph.D. in Biomedical Engineering from Johns Hopkins School of Medicine where she focused on the development of novel therapies for treating spinal cord injury.

Fred Khosravi  
Executive Chairman and Co-Founder


Fred (Farhad) Khosravi is the Chairman and CEO of Imperative Care and sits on the board of NeuroLutions. Fred is also the Managing Director of Incept LLC, an Innovations Accelerator he founded with Amar Sawhney in 1998. Together, Incept has founded or co-founded twenty-three innovative startup companies with fourteen exits including to IPO, Boston Scientific, Medtronic, Cardinal Health and Teleflex, among others. Incepts companies have developed products that treat over a million patients worldwide every year. Prior to his entrepreneurial career, Fred was Engineering Manager in the initial management team at Focal, Inc. (acquired by Genzyme Biosurgery), responsible for its cardiovascular products. He was also the Business Unit Manager of the Stent Business at Guidant/ACS where he led the initial design and development team of the highly successful Multilink stent. Prior to ACS (from 1986 through 1989) he held several management positions with Alcon Surgical. Fred is the author or co-author on over 40 medical device patents. Fred has a B.S. degree in Mechanical Engineering and graduated cum laude, obtaining a Master of Science degree in Mechanical Engineering from Tennessee Tech University.

Henry Chen
Co-Founder and Director


Henry is the Managing Partner and co-Founder of Delos Capital.  Mr. Chen also sits on the boards of Imperative Care, BaroNova, Atia Vision, Tanvex BioPharma, Allecra Therapeutics and Syndax Pharmaceuticals.  Prior to establishing Delos in 2014, Mr. Chen was a Partner and Co-Head of Asia at Permira, a European private equity firm with global reach and a total committed capital of approximately €20bn. While at Permira, Mr. Chen worked on a number of transactions including Asia Broadcast Satellite and Galaxy Entertainment Group. Prior to joining Permira in 2008, Mr. Chen spent nine years in Investment Banking at Goldman Sachs, where he was a Managing Director and co-headed the General Industrials Group, Asia (excluding Japan) which covered consumer retail, healthcare, industrials and transportation sectors. Prior to that, Mr. Chen was a corporate finance lawyer with Davis Polk in New York and Hong Kong. Mr. Chen holds Bachelor and Masters degrees from Harvard University and has a Juris Doctorate degree from Harvard Law School.